Chapter 7: Genomic Uracil and Cancer

New technologies have made possible sequencing of a large number of whole cancer genomes and exomes. Such studies have identified sequence-associated mutational signatures in human cancers. These frequently suggest a causative mutational agent, thus shedding light on the molecular mechanisms of oncogenesis and cancer progression. Analysis of mutational signatures may also be used to monitor response to therapy…